Showing results (311-320 of 412) with videos related to
Sort By:
Pageof 42
European Journal of Endocrinology|July 25, 1998
Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and womenJ A Janssen, H Burger, R P Stolk, et al.The Journal of Clinical Endocrinology and Metabolism|November 1, 1988
Successful treatment with SMS 201-995 of Cushing's syndrome caused by ectopic adrenocorticotropin secretion from a metastatic gastrin-secreting pancreatic islet cell carcinomaS W Lamberts, H W Tilanus, A I Klooswijk, et al.The Journal of Clinical Endocrinology and Metabolism|June 1, 1993
In vivo somatostatin receptor imaging in medullary thyroid carcinomaD J Kwekkeboom, J C Reubi, S W Lamberts, et al.Journal of Hypertension|February 1, 1996
Insulin, hypertension and antihypertensive drugs in elderly patients: the Rotterdam StudyR P Stolk, A W Hoes, H A Pols, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1991
Radioiodinated somatostatin analog scintigraphy in small-cell lung cancerD J Kwekkeboom, E P Krenning, W H Bakker, et al.Neuroendocrinology|March 1, 1990
Evidence for the involvement of corticotropin-releasing factor in the inhibition of gonadotropin release induced by hyperprolactinemiaA Kooy, W J de Greef, J T Vreeburg, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1993
Octreotide scintigraphy for the detection of paragangliomasD J Kwekkeboom, H van Urk, B K Pauw, et al.Clinical Endocrinology|October 27, 2001
Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretionA F Muller, J A Janssen, S W Lamberts, et al.International Journal of Cancer|January 3, 1995
Role of tumor-derived fibroblasts in the growth of primary cultures of human breast-cancer cells: effects of epidermal growth factor and the somatostatin analogue octreotideL J Hofland, B van der Burg, C H van Eijck, et al.British Journal of Cancer|October 1, 1990
Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effectsJ G Klijn, A M Hoff, A S Planting, et al.Pageof 42